Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$235.51 - $267.98 $294,151 - $334,707
1,249 Added 3.2%
40,295 $10.1 Million
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $203,918 - $232,620
-908 Reduced 2.27%
39,046 $9.75 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $1.52 Million - $1.91 Million
-8,186 Reduced 17.0%
39,954 $9.24 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $526,993 - $600,498
2,261 Added 4.93%
48,140 $11.9 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $479,678 - $546,090
-2,132 Reduced 4.44%
45,879 $11 Million
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $574,680 - $663,969
2,397 Added 5.25%
48,011 $12.1 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $1.06 Million - $1.24 Million
4,395 Added 10.66%
45,614 $12.1 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $65,223 - $397,953
-264 Reduced 0.64%
41,219 $10.6 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $2.35 Million - $2.97 Million
9,897 Added 31.33%
41,483 $10.5 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $1.72 Million - $2.12 Million
-6,702 Reduced 17.5%
31,586 $9.27 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $96,970 - $109,231
332 Added 0.87%
38,288 $12.6 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $96,090 - $117,347
-353 Reduced 0.92%
37,956 $11.6 Million
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $120,417 - $145,354
535 Added 1.42%
38,309 $10.3 Million
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $125,516 - $145,326
591 Added 1.59%
37,774 $8.5 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $1.27 Million - $1.46 Million
-5,958 Reduced 13.81%
37,183 $8.26 Million
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $4.26 Million - $5.18 Million
-24,040 Reduced 35.78%
43,141 $9.29 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $4.36 Million - $5.99 Million
-33,865 Reduced 33.51%
67,181 $11.9 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $11 Million - $15.4 Million
-91,020 Reduced 47.39%
101,046 $14 Million
Q4 2019

Feb 13, 2020

SELL
$133.47 - $153.48 $4.06 Million - $4.67 Million
-30,434 Reduced 13.68%
192,066 $29.5 Million
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $3.94 Million - $4.26 Million
-29,080 Reduced 11.56%
222,500 $32.1 Million
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $26.5 Million - $30.5 Million
-212,541 Reduced 45.79%
251,580 $36 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $7.19 Million - $9.74 Million
-73,624 Reduced 13.69%
464,121 $61.3 Million
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $38.7 Million - $44.7 Million
-407,933 Reduced 43.14%
537,745 $55.5 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $6.85 Million - $7.6 Million
69,817 Added 7.97%
945,678 $103 Million
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $8.75 Million - $9.4 Million
-91,023 Reduced 9.41%
875,861 $86.4 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $6.69 Million - $7.53 Million
72,571 Added 8.11%
966,884 $94.7 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $25.2 Million - $27.9 Million
-295,171 Reduced 24.82%
894,313 $83 Million
Q3 2017

Nov 14, 2017

SELL
$79.29 - $88.45 $941,965 - $1.05 Million
-11,880 Reduced 0.99%
1,189,484 $102 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $6.28 Million - $7.01 Million
79,225 Added 7.06%
1,201,364 $103 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,122,139
1,122,139 $94.7 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cramer Rosenthal Mcglynn LLC Portfolio

Follow Cramer Rosenthal Mcglynn LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.